Novavax prices stock offering

|By:, SA News Editor

Novavax (NVAX) prices its public offering of 25M shares of common stock at $4.00 per share. Underwriters over-allotment is 3.75M shares. Net proceeds of ~$94M will be used for general corporate purposes, the advancement of its clinical-stage vaccine candidates, its preclinical research programs, manufacturing and process development activities, CAPEX and other strategic purposes. Closing date is June 11.